Researchers from the National Physical Laboratory (NPL; Teddington, Middlesex, England) and MedImmune (Gaithersburg, MD), the global biologics research and development arm of Astra Zeneca, are collaborating to investigate, with super-resolution microscopy, the use of exosomes for targeted delivery of therapeutics.